The U.S. Food and Drug Administration (FDA) has long suppressed dimethyl sulfoxide (DMSO), a natural compound extracted from trees, despite over 10,000 scientific studies demonstrating its safety and therapeutic benefits for conditions including chronic pain, inflammation, and cancer.

Medical researcher Mike Adams notes that DMSO was initially celebrated in the 1960s and 1970s as a breakthrough treatment. However, the FDA launched a campaign to ban it, claiming it posed safety risks without sufficient evidence.

DMSO has been used safely by veterinarians for decades to treat racehorses and athletes. Case studies report complete remission of cervical cancer when DMSO was combined with hematoxylin—a plant dye that triggers cancer cell death.

The FDA restricts DMSO for human medical applications while approving toxic medications that cause severe side effects.